+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Metronidazole Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Metronidazole Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Ulcerative Colitis (UC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
Anal Fistula - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Fistula - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2024 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Opioid-Induced Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid-Induced Constipation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Functional Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Functional Constipation - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Abdominal Aneurysms - Pipeline Insight, 2024 - Product Thumbnail Image

Abdominal Aneurysms - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiation-induced Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Radiation-induced Esophagitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Functional Dyspepsia - Pipeline Insight, 2024 - Product Thumbnail Image

Functional Dyspepsia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Diabetic Hypoglycemia - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Hypoglycemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chemotherapy-Induced Diarrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy-Induced Diarrhea - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Intestinal Mucosal Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Intestinal Mucosal Injury - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Postoperative Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Postoperative Nausea and Vomiting - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Norovirus Enteritis - Pipeline - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Norovirus Enteritis - Pipeline - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more